FOXP3 and bladder transitional cell carcinoma: Previously, we have shown the clinical correlation of FOXP3 expression to worse overall survival in patients with urothelial bladder cancer as well as the induction of genes that mediate cancer cell differentiation and chemotherapy resistance (14).